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Abstract
Aim: To study health related quality of life (HRQOL) and depressive symptoms in adolescents with chronic fatigue
syndrome (CFS) and to investigate in which domains their HRQOL and depressive symptoms differ from those of
healthy adolescents.
Background and objective: Several symptoms such as disabling fatigue, pain and depressive symptoms affect
different life domains of adolescents with CFS. Compared to adolescents with other chronic diseases, young people
with CFS are reported to be severely impaired, both physiologically and mentally. Despite this, few have
investigated the HRQOL in this group.
Method: This is a cross-sectional study on HRQOL including 120 adolescents with CFS and 39 healthy controls (HC),
between 12 and 18 years. The Pediatric Quality of Life Inventory™, 4.0 (PedsQL) was used to assess HRQOL. The
Mood and Feelings Questionnaire assessed depressive symptoms. Data were collected between March 2010 and
October 2012 as part of the NorCAPITAL project (Norwegian Study of Chronic Fatigue Syndrome in Adolescents:
Pathophysiology and Intervention Trial). Linear and logistic regression models were used in analysis, and all tests
were two-sided.
Results: Adolescents with CFS reported significantly lower overall HRQOL compared to HCs. When controlling for
gender differences, CFS patients scored 44 points lower overall HRQOL on a scale from 0–100 compared to HCs.
The domains with the largest differences were interference with physical health (B = −59, 95 % CI −54 to −65) and
school functioning (B = −52, 95 % CI −45 to −58). Both depressive symptoms and being a patient were
independently associated with lower levels of HRQOL
Conclusion: The difference in HRQOL between CFS patients and healthy adolescents was even larger than we
expected. The large sample of adolescents with CFS in our study confirms previous findings from smaller studies,
and emphasizes that CFS is a seriously disabling condition that has a strong impact on their HRQOL. Even though
depressive symptoms were found in the group of patients, they could not statistically explain the poor HRQOL.
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Background
Chronic fatigue syndrome (CFS) is a well-known, disab-
ling and long-lasting condition with an estimated preva-
lence of 0.1 % to 1.0 % in children and adolescents
(Nijhof et al. 2011, Crawley et al. 2011). The criteria
from the Centers for Disease Control and Prevention
(CDC), are most frequently used [1], and are also cited
as the Fukuda-criteria. CFS is characterized by an unex-
plained disabling chronic or relapsing physical and men-
tal fatigue of new onset lasting for more than six
months, which is not relieved. It is combined with four
or more of the eight specified accompanying symptoms:
headache, muscle pain, joint pain, sore throat, tender
lymph nodes, impaired memory or concentration, unre-
freshing sleep, and malaise after exertion [1]. For chil-
dren and adolescents, specific pediatric criteria have
been introduced, requiring only three months of fatigue
and only one additional symptom [2, 3]. Both pain and
fatigue have great impact on physical activity [4], which
again might act as a disease-maintaining factor [5].
Young people with CFS have reported more pronounced
impairment, with reduced school attendance, compared
with a corresponding sample of juvenile idiopathic arth-
ritis [6]. This may be critical, as adolescents are in a vul-
nerable stage of life when social interaction with peers is
highly important [7]. Depression is shown to be common
in this group, but the causal relationship between CFS and
depression is still unknown [8]. More important in this
setting, anxiety and depression seem to be intensified by
social isolation [9]. A previous qualitative study among
healthy adolescents has shown that friends are one of the
most important factors for HRQOL [10]. In the recent
qualitative study from our group, the adolescents with
CFS described a feeling of being different and forgotten
when not being able to interact with friends or attend
school [11]. CFS affects several life domains, and in adult
CFS samples HRQOL has shown to be poor [12, 13].
However, few studies have thoroughly investigated the
HRQOL perspective among adolescents with CFS. In a
small study, including 25 children with CFS, Kennedy
et al. [14] found that HRQOL was significantly more re-
duced compared with children and adolescents suffering
from other chronic conditions.
Health-related quality of life (HRQOL) is a multidi-
mensional construct consisting of different domains
from physical, psychological, social and spiritual issues
[15]. The functional capacity is affected in adolescents
with CFS, but there is a lack of knowledge about phys-
ical impairment and how the impairments affect their
HRQOL. When Kennedy et al. [14] assessed HRQOL
among 25 children with CFS, they found physical health
to be the most seriously affected domain. In other stud-
ies on this group, both physical and psychological func-
tioning have been found to be particularly poor [16].
Our research group found that adolescents with CFS
have a reduced level of activity measured as reduced
number of steps daily [17]. This may have led to in-
creased body mass index (BMI) [18] and poor physical
quality of life [19].
The aims of this paper were to examine HRQOL and
depressive symptoms in adolescents with CFS and to com-
pare HRQOL and depressive symptoms with a group of
healthy adolescents. We hypothesized that adolescents
with CFS report lower HRQOL and have a higher degree
of depressive symptoms compared to HCs.
Material and methods
Design
This is a cross-sectional study which describes HRQOL
in adolescents with CFS and compares the HRQOL with
a group of healthy adolescents. The study is part of the
NorCAPITAL-project (The Norwegian Study of Chronic
Fatigue Syndrome in Adolescents: Pathophysiology and
Intervention Trial; Clinical Trials ID: NCT01040429)
which explores possible mechanisms of CFS, the effect
of low-dose clonidine treatment, and patients’ experi-
ences in adolescents with CFS [17].
Study population
CFS patients
One hundred and twenty adolescents with CFS and 39
healthy adolescents were recruited between March 2010
and October 2012. All pediatric departments in Norwegian
hospitals (n = 20), as well as primary care pediatricians and
general practitioners, were invited to refer adolescents with
CFS (aged 12–18 years) to a central Norwegian department
of pediatrics. The referring units were required to confirm
that the patients did not have any medical or psychiatric
disorder that might explain the fatigue. In agreement
with clinical guidelines [2, 3] a “broad” case definition
with three months of unexplained, disabling fatigue of
new onset was required. We also required that the pa-
tient was not permanently bedridden and did not use
pharmaceuticals (including hormone contraceptives)
regularly. Those who fulfilled the pre-specified criteria
for inclusion (Table 1), went through a thorough medical
examination before they were invited to take part in the
Nor CAPITAL study.
A control group of healthy adolescents
To recruit a control group of healthy adolescents, in-
formation about the study was sent to local schools.
Those who replied, were given extended information.
No regular use of pharmaceuticals (including hormones)
was required to be included. A group of 39 healthy and
normally active adolescents and comparable on gender
and age, was enrolled. The HCs, however, were not ac-
tively matched.
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Measures
Body Mass Index
Research in children and adolescents shows that over-
weight and obesity have impact on their HRQOL [20].
According to The Norwegian Directorate of Health [21],
BMI is calculated as weight in kilograms divided by
height in squared meters and is adjusted for age and
gender. We decided to transform BMI into a categorical
variable with three categories; BMI < 25 (normal weight),
25 ≤ BMI <30, and BMI ≥ 30 (Table 1). Weight and
height were measured by the researchers.
PedsQL
To measure HRQOL we used the Pediatric Quality of
Life Inventory™, 4.0 (PedsQL), which is a 23-item generic
questionnaire developed to measure HRQOL in healthy
children and adolescents, as well as in pediatric popula-
tions with acute and chronic health conditions [22]. The
questions cover all the health domains stated by WHO
including school functioning [23] and are suitable for chil-
dren and adolescents aged between 5 and 18 years. Corre-
sponding questionnaires for proxies exist (there are
several versions dependent on age). The PedsQL provides
a total sum score and four subscale scores in the following
domains; (1) physical functioning (8 items), (2) emotional
functioning (5 items), (3) social functioning (5 items), and
(4) school functioning (5 items). Three of the subscales
(emotional, social, and school functioning) are combined
to provide a specific scale for psychosocial health. Partici-
pants are asked to rate the severity of each item during
the previous month by a Likert Scale from 0 (never a
problem) to 5 (a lot of a problem). Items are reverse-
scored and linearly transformed on a scale ranging from
0–100 (0 = 100, 1 = 75, 2 = 50, 3 = 25, 4 = 0), where higher
scores indicate better HRQOL. Each subscale score is
computed as the sum of points from each item divided by
the number of items answered [23]. The instrument has
been translated into several languages, among these
Norwegian, and validated [24]. Scale internal consistency
was measured with Cronbach’s alpha, varying between
0.77 and 0.88, which is considered good [24].
The mood and feelings questionnaire
Levels of depressive symptoms were identified using
The Mood and Feelings Questionnaire (MFQ) which is
validated for children and adolescents [25]. MFQ consists
of 33 items with three alternative answers (not true = 0,
sometimes = 1, true = 2). Total score ranges from 0 to 66.
A score ≥ 20 implies presence of depressive symptoms
to a degree that suggests mood disorder [25], and was
therefore chosen as the cutoff. MFQ has been used in
several Norwegian studies [26–28], showing good internal
consistency [26].
Also the PedsQL includes questions concerning
depression-like symptoms. These questions, however,
are phrased differently and cover slightly different areas
compared to questions in MFQ. Moreover, the questions
covering depressive symptoms, are to be scored differ-
ently, and represent only a part of the overall score. We
thus found it meaningful to model associations between
HRQOL and depressive symptoms.
Ethical considerations
The study was approved by the Norwegian Social Science
Data Service and by the Norwegian Regional Committee
for Medical and Health Research Ethics. Participation in
the project required informed consent by the adolescent
and by his or her parents/next-of-kin after written and
oral information about the study.
Table 1 Criteria for inclusion and exclusion




Persisting or constantly relapsing
fatigue lasting 3 months or more.
Age≥ 12 years
and < 18 years
Functional disability resulting from
fatigue to a degree that prevent
normal school attendance
Age≥ 12 and < 18 years
Exclusion
criteria:
Another current process or chronic
disease or demanding life event







Permanent use of pharmaceuticals
(including hormones) possibly




Evidence of reduced cerebral and/or





clonidine or inert substances (lactose,
saccarose) in capsula
Abnormal ECG (apart from ectopic beats)
Supine heart rate < 50 beats/min
Supine systolic blood pressure <
85 mmHg
Upright systolic blood pressure
fall > 30 mmHg
The criteria are designed for the randomized control trial in the NorCAPITAL-
project (The Norwegian Study of Chronic Fatigue Syndrome in Adolescents:
Pathophysiology and Intervention Trial; Clinical Trials ID: NCT01040429), which
explores possible mechanisms of CFS, the effect of low-dose clonidine treatment,
and patients’ experiences as adolescents with CFS (9)
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Statistical analyses
Continuous data (age and disease duration) are pre-
sented as means with SD while categorical data (gender,
parents’ education and BMI) are presented as numbers
and percentages. Differences between CFS patients and
HCs were assessed with Chi-square test analyses for the
independent categorical variables gender and BMI.
To further investigate the differences between CFS pa-
tients and HCs, we fitted a linear regression model with
overall HRQOL score and the sub-scores for each domain
as dependent variables. We moreover adjusted for gender,
depressive symptoms and categories of BMI. The factor
BMI, however, did not reach statistical significance and
was excluded from further analysis. The risk of having de-
pressive symptoms (a dichotomized dependent variable)
was modeled using logistic regression and adjusted for
gender and BMI.
Both regression models fitted the data well (goodness of
model fit), and all residuals were approximately normally
distributed (linear regression). The results are presented
as estimates of beta (B) with 95 % confidence intervals
(CI). The results of logistic regression are presented as
odds ratios (OR) with 95 % CI. All tests were two-sided,
and P-values <0.05 were considered statistically significant.
All analyses were performed using IBM SPSS statistics
version 21.
There were almost no missing data in any of the data
sets. Values were imputed for individuals when less than
10 % of the values were missing by using the mean score
for each variable. Individuals who had more than 10 %
missing values in total, were excluded.
As a result of difficulties in recruitment of healthy
controls, our sample of HCs was smaller than the group
of adolescents with CFS. We therefore compared the
average levels of the HCs with corresponding levels in
the healthy population in the Norwegian validation study
of the PedsQL [24], and the control group of HCs in the
study by Diseth and coworkers [29] including children/
adolescents subjected to renal transplantation (TX) and
children in remission after acute lymphoblastic leukemia
(ALL). Confidence intervals were not available in these
studies, but knowing the mean and SD, we could com-
pute the CI making it possible to compare the data.
Results
In total, we included 120 adolescents with CFS and 39
healthy adolescents as controls. Participants were com-
parable regarding age (mean 15.4 for CFS patients and
mean 15.2 for HCs), and gender (72 % girls in both the
CFS and HC group).
The comparison of our relatively small group of HCs
with other studies using PedsQL to measure HRQOL in
children, suggest that our sample of HCs is a representa-
tive control group (Table 2).
Almost all the patients had suffered from CFS for a
long period of time (mean 21.4 months) (Table 3), and
only two patients had a short disease duration of be-
tween three and six months.
As there was no difference between the CFS group and
HCs concerning demographics such as parents’ education
(Table 3) and ethnicity (data presented elsewhere [17]), we
did not need to adjust for these variables when assessing
group differences. The CFS group had a slightly higher
mean BMI, but the group difference did not reach statis-
tical significance.
When adjusted for gender, CFS patients had significantly
lower overall HRQOL than did the HCs (44 HRQOL
points, B = −44, 95 % CI (−39.6 to −48.6)) (Table 4), and
for each subscale the group differences were even more
pronounced; on a scale from 0–100 it was 60 points lower
for physical functioning, 52 points lower for school func-
tioning, 28 points lower for emotional functioning, and 27
points lower for social functioning. Concerning psycho-
social HRQOL, the CFS patients had on average 33 points
lower scores than HCs, independent of gender and BMI
(Fig. 1 and Table 5).
Table 2 Comparing PedsQL results from the NorCAPITAL study with two other studies
NorCAPITAL study Reinfjell et al. 2006
[24]
Diseth et al. 2011
[29]
Diseth et al. 2011
[29]













CIMean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Variable N = 120 N = 39 N = 425 N = 42 N = 38 N = 40
Age 12-18 12-18 13-15 3-19 3-19 3-19
Overall QoL 49 (13) 46-51 93 (8) 89-96 85 (11) 84-86 89 (8) 87-91 69 (18) 63-75 82 (13) 78-86
Physical health 37 (17) 33-40 96 (8) 92-99 91 (10) 90-92 92 (6) 90-94 75 (17) 69-81 86 (12) 82-90
Emotional functioning 60 (18) 56-63 88 (14) 83-94 77 (17) 75-79 83 (13) 79-87 69 (16) 61-74 75 (19) 69-81
Social functioning 70 (15) 68-73 98 (4) 97-99 88 (13) 87-89 93 (8) 90-96 74 (22) 67-81 86 (14) 82-90
School functioning 36 (19) 33-39 88 (14) 81-93 78 (15) 77-79 86 (13) 82-90 63 (18) 57-69 77 (16) 72-82
Psychosocial functioning 57 (15) 54-60 91 (10) 88-96 82 (13) 81-83 87 (9) 84-90 67 (18) 61-73 79 (14) 75-83
HRQOL is assessed by PedsQL
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Figure 1 depicts point-estimates for HRQOL for CFS
patients and controls with standard errors of the mean
values for sum-score and sub-scores for each domain.
The estimates show a high precision due to the high
number of CFS patients and the homogeneity of the
control group. The specific values are presented in
Table 5.
Regarding gender differences, girls (both adolescents
with CFS and HCs) demonstrated a 5 points lower over-
all HRQOL level (B = −4.7, 95 % CI (−8.9 to −0.5)) com-
pared to boys. This was also the case for the subscales
physical health (B = −5.9, 95 % CI-11.3 to −0.5) and
emotional functioning (B = −7.3, 95 % CI −13.4 to −1.3).
Logistic regression analysis indicated an eight times
higher risk of depressive symptoms when having CFS
compared to HCs (OR = 7.9, 95 % CI 2.3-27.4). When
modeling quality of life using linear regression, higher
levels of depressive symptoms were inversely associated
with higher levels of HRQOL both in CFS patients and
in HCs. Further, we modelled HRQOL with multiple lin-
ear regression. When depressive symptoms was entered
as a covariate, we only uncovered an additive effect of
depressive symptoms and no interaction between having
a higher level of depressive symptoms and being a CFS
patient. Thus having a higher level of depressive symp-
toms was associated with the same change of effect on
HRQOL in CFS patients and HCs, and the strength and
size of the association between being a CFS patients and
HRQOL were not changed when adjusted for depressive
symptoms. We therefore conclude that both depressive
symptoms and being a patient were independently asso-
ciated with lower levels of HRQOL.
Discussion
Our findings show that adolescents with CFS have a sig-
nificantly lower quality of life compared with healthy
controls, demonstrated by lower overall HRQOL score
and sub-score levels for specific HRQOL domains. De-
pressive symptoms were found in both adolescents with
CFS and HCs, but the score levels were higher among
the adolescents with CFS. The low HRQOL level in the
CFS group was not explained by depressive symptoms
but by having CFS.
Health related quality of life and depressive symptoms
This is the first large study investigating HRQOL in ado-
lescents with CFS. Both overall HRQOL and the subscale-
scores for different life domains were lower compared to
HCs, in line with the results from a smaller, previous study
which included 25 adolescents with CFS [14]. The group
differences in our study were not explained by gender,
BMI or socio-demographic differences.
Although depressive symptoms is found to be the
main predictor for reduction in daily functioning in
adults with CFS [30], the cause effect relation between
CFS and depression is still debated [8]. Skapinskis et al.,
studying an adult population, proposed that depression
might lead to CFS [31], while Bould and coworkers, on
the contrary, suggested that the experience of having
CFS could explain depressive traits in adolescents with
CFS [32]. The CFS patients in our sample showed an
Table 3 Demographic data and adherence to the CDC-criteria
for CFS
CFS patients Controls
N = 120 N = 39
Variable n (%) n (%)
Male 34 (28) 11 (28.2)
Female 86 (72) 28 (71.8)
CDC criteria 88 (74) NA
Lives together with both parents 85 (73) 26 (70)
BMI (adjusted for age and gender)
Normal weight (BMI <25) 100 (83.3) 37 (94.9)
Moderate overweight (25≤ BMI < 30) 14 (11.7) 2 (5.1)
Severe overweight (BMI ≥30) 6 (5.0) 0 (0)
MFQ (depressive symptoms)a 47 (39) 3 (8)
Parents highest education
Primary school 5 (4.3) 0 (0)
Secondary school 30 (26) 8 (23)
Lower university 34 (29) 9 (23)
Higher university 48 (41) 19 (54)
Mean (SD) Mean (SD)
Age 15.4 (1.6) 15.2 (1.6)
Disease duration (months) 21.4 (15.2) NA
School absence %b 65 (30) 2.1 (6.8)
aMFQ (Mood and feelings Questionnaire) score >20 suggests depressive
symptoms and was the cutoff chosen. NA = not applicable. bSchool absence
was calculated as the ratio between mean days absent from school last month
and days supposed to be at school last month. These proportions are
presented as mean values with SD
Table 4 Comparison of health related quality of life between
adolescents with CFS and HCs
Variable Items Estimate of B 95 % CI p-value
Overall HRQOL 23 −44 (−49; −40) <0.001
Physical health 8 −60 (−54; −66) <0.001
Emotional functioning 5 −28 (−22; −35) <0.001
Social functioning 5 −27 (−22; −33) <0.001
School functioning 5 −52 (−45; −58) <0.001
Psychosocial functioning 15 −36 (−31; −41) <0.001
HRQOL was assessed by the Pediatric Quality of Life Inventory™, 4.0 (PedsQL).
The listed estimates express the difference between adolescents with CFS and
healthy controls. Multiple linear regression for total score and subscale scores
are adjusted for gender differences between the groups. CFS: N: =114,
HHCs: N = 36
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eight times higher risk of having a mood disorder, but a
higher level of depressive symptoms had statistically the
same effect on HRQOL in both groups. Our model
showed that having depressive symptoms and having CFS
independently explained the low HRQOL scores. Thus,
being a CFS patient was an independent factor explaining
the lower HRQOL, and it was not confounded by depres-
sive symptoms.
We chose a low cut-off indicating mood disorders and
not a clinical relevant cut-off screening for major de-
pression. This might be the reason for the relatively high
proportion of HCs (8 %) with depressive symptoms.
Emotional functioning
On emotional functioning, our CFS population scored
60 out of maximum 100 points; 30 points lower than
the group of healthy adolescents. Even though we used
a different questionnaire, the results are almost equal
to Kennedy et al. who found 54 points out of 100 on
emotional function. Alexithymia, which means difficul-
ties in experiencing, expressing, and describing emo-
tional responses, has been suggested as a factor in the
development of medically unexplained diseases such as
CFS. In a study by van de Putte et al. [33], however, alex-
ithymia did not correlate as a unique factor to CFS and
did not appear as a prognostic factor for recovery from
CFS. A study by Garralda & Rangel [6] has shown that
children with CFS use more emotional regulation or res-
ignation and fewer problem-solving strategies to deal
with disabilities compared with other children. Experi-
encing difficult thoughts and sad feelings (depressive
symptoms) might not be surprising, considering the
consequences of the disease, such as reduced school
attendance and time with peers. Thus, it should be of
importance to support the adolescents in handling sad
and difficult feelings.
Physical functioning
Despite the sparse number of studies on HRQOL in ad-
olescents, those which are available address domains like
physical impairment and school attendance [34, 4, 35]. It
should be borne in mind that physical health in PedsQL
includes both physical activity, the feeling of low energy,
and pain as an unpleasant bodily symptom [23], as they
are all interconnected. Low mood and fatigue are associ-
ated with worse physical function and are the strongest
predictors for school absence [4].
The fact that physical health and school functioning
were most affected in our sample, might not be surprising
considering the nature of CFS. Garralda and Rangel
(2004) have demonstrated that children (10–18 years) with
CFS are even more impaired compared with children with
juvenile idiopathic arthritis (9–18), especially when it
comes to schoolwork, expectations and attendance. This
was also the case when compared with children with type
1 diabetes and asthma [14]. We further compared our
findings (Table 2) with a recent Norwegian study on
HRQOL including children and adolescents subjected to
renal transplantation (TX) (with a median age since trans-
plantation at 4.9 years), and children in remission after
Fig. 1 Health Related Quality of Life among Adolescents with CFS and Healthy Controls. (Detailed Legend Fig. 1): HRQOL was assessed by the Pediatric
Quality of Life Inventory™, 4.0 (PedsQL). Total score and subscales scores are presented by mean values and SD. CFS: N: =114, HCs: N = 34
Table 5 Health related quality of life among adolescents with
CFS and HCs
Scores, Mean (SD) Scores, Mean (SD)
Adolescents with CFS Healthy Controls
(n = 114) (n = 36)
Overall HRQOLa 48.8 (13.0) 92.9 (8.2)
Physical health 36.5 (17.2) 96.0 (8.1)
Emotional functioning 59.8 (18.2) 88.1 (14.0)
Social functioning 70.0 (15.1) 97.8 (3.9)
School functioning 36.0 (18.8) 87.6 (13.9)
Psychosocial functioningb 55.4 (13.1) 91.2 (8.9)
HRQOL was assessed by the Pediatric Quality of Life Inventory™, 4.0 (PedsQL)
aSum score of all questions. bCombined score of emotional, social and school
functioning. Total score and subscales scores are presented as mean values
with SD
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acute lymphoblastic leukemia (ALL) [29]. Our study sug-
gests that adolescents with CFS were even more interfered
by their illness than adolescents with renal TX and ALL.
We have previously reported that our CFS patients per-
formed a significantly lower number of steps per day [17],
suffered from more severe pain, and had a lower pressure
pain threshold than HCs [36]. The low activity among
CFS patients might stem from the feeling of extreme
fatigue and/or activity-related pain. When experiencing
malaise and pain after even normal activity, patients may
easily develop a fair avoidance behavior [35] as demon-
strated among adults with CFS [37]. Gray and Rutter [38]
identified two important factors for predicting physical
functioning in adolescents with CFS: adolescents who
adapted to the illness (using Leventhal’s self-regulation
model measuring) reported a better quality of life, and
those who managed to maintain some degree of activity
reported better physical outcomes. A stronger focus on
symptoms was by contrast associated with poorer HRQOL.
The authors suggested that adapting to the illness might
act as a mediator, leading to better coping strategies.
School functioning as a factor for social interaction
In our study, school functioning was the most affected
HRQOL domain, with a score level (Fig. 1, Table 3) sub-
stantially lower compared with previous studies on CFS
patients [14, 39, 6]. In a qualitative study, recently pub-
lished, we explored adolescents’ own experience of living
with CFS, and found that lack of participation at school
and in teen venues made them feel like outsiders [11].
This is a serious finding, considering that a good relation
to friends is one of the most important factors for
HRQOL in healthy adolescents [10]. Other studies on
adolescents with CFS have similarly emphasized the need
for friends as an important factor for well-being [9, 40].
The adolescents with CFS experienced loss of a normal
life, and the changes in friendships as difficult, leading to
loneliness and isolation [9].
School is surely an institution for learning and intellec-
tual activities, but is also an arena for socializing. Previ-
ously, we have reported that some of the adolescents
managed to shift focus from friends and school towards
other arenas like their family, and appreciated their sup-
port [11]. Thus, relational factors within the family seem
to be even more important for children with CFS than
those with other chronic conditions [41]. In this way,
however, adolescents with CFS might become even more
dependent on care-givers [35] which may hinder grow-
ing towards independence. This dilemma underpins the
importance of involving the family in treatment. The
dramatic changes following low school functioning may
have serious educational and social implications [4]. A
study on school drop-outs in adolescents with chronic
somatic diseases found an increased risk of sickness and
disabilities later in young adulthood [42]. To minimize
school drop-out and the risk of long term consequences,
the authors pointed to the importance of early intervention.
HRQOL and gender differences
Looking at gender difference, the overall scores of
HRQOL were lower among girls compared to boys, both
in the CFS and the HC group. Gender differences have
also been demonstrated in previous HRQOL studies [24]
and are not unique in adolescents with CFS.
Strengths and limitations
The Nor CAPITAL study had one clear selection bias, as
the study included only patients who were able to attend
our research clinic; and the results can therefore not be
extrapolated to the most seriously affected CFS adoles-
cents. Secondly, the number of HCs in our study was
only one third compared to the group of CFS patients.
We therefore additionally compared the average levels of
the HCs with corresponding levels from the healthy
population in the Norwegian validation study of the
PedsQL [24] and the control group of HCs in a study by
Diseth and coworkers [29] (Table 2). The comparison
with the other studies suggest that our sample of HCs is
a representative control group.
Validating MFQ, Daviss et al. [25] suggested two differ-
ent cutoffs which differentiate between depressive symp-
toms (cutoff ≥20), and major depression (cutoff ≥29). The
relatively high proportion of patients with depressive
symptoms in our study might be explained by the low
cutoff value. Although depressive symptoms were only
found to have an additive effect on HRQOL, this does
not change the fact that adolescents with CFS report
seriously poor HRQOL.
What this study adds
The large study population contributes to underpin an
area almost not studied and documented in this popula-
tion. The study provides new knowledge about how bad
the life of these adolescents are, and their HRQOL was
even poorer than we expected. The poor HRQOL was
explained by the illness and not by depressive symptoms.
The relatively large study population with few missing
data makes it possible to generalize the findings.
Conclusion
The large sample of adolescents with CFS in our study
confirms previous findings from smaller studies and em-
phasizes that CFS is a seriously disabling condition that
has strong impact on their HRQOL. Compared to
healthy adolescents, HRQOL in adolescents with CFS
was even poorer than we expected, and physical function
and school function showed the lowest sub-scores. Even
though depressive symptoms were found in the group of
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patients, they could not statistically explain the poor
HRQOL.
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